Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1424-2014

Drug recall · July 16, 2014

Labetalol Hydrochloride Injection recall

Why: Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20

Lots / codes

Lot 36225DD, exp 12/01/2015

Quantity
45,448 vials
Company
Hospira Inc., Lake Forest, IL
Distribution
Nationwide
Initiated
May 16, 2014 · Voluntary: Firm initiated
Classified
July 8, 2014
Reported
July 16, 2014
Ended
March 16, 2017
How notified
Press Release

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Labetalol

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.